{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-dyspnoea/background-information/causes-of-dyspnoea/","result":{"pageContext":{"chapter":{"id":"ea086054-ae8f-5666-9159-99b04676d230","slug":"causes-of-dyspnoea","fullItemName":"Causes of dyspnoea","depth":2,"htmlHeader":"<!-- begin field ba276300-db5e-4bcb-8218-1e9d19d25386 --><h2>What are the causes of dyspnoea?</h2><!-- end field ba276300-db5e-4bcb-8218-1e9d19d25386 -->","summary":"","htmlStringContent":"<!-- begin item 949613d1-5c5f-44b4-be14-bddc610b1842 --><!-- begin field b995f8ec-7332-499c-b123-da7e3df1f04f --><ul><li>Dyspnoea can result from impaired ventilation or increased ventilatory demand, or both factors. However, in some people no cause is found, even after thorough assessment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Davis, 1997</a>]. There are a wide range of causes of dyspnoea in people with cancer.</li><li><strong>Dyspnoea may be a direct result of cancer including:</strong><ul><li>Tumour involving lung parenchyma (primary tumour or metastasis).</li><li>Upper and lower airway obstruction by tumour.</li><li>Lymphangitis carcinomatosa.</li><li>Pleural tumour (mesothelioma).</li></ul></li><li><strong>Indirect effects of cancer may also cause </strong><strong>dyspnoea:</strong><ul><li>Pleural effusion.</li><li>Pericardial effusion.</li><li>Phrenic nerve paralysis.</li><li>Tumour microemboli.</li><li>Superior vena cava syndrome.</li><li>Cachexia.</li><li>Anaemia.</li><li>Aspiration.</li><li>Surgery (pneumonectomy or lobectomy).</li><li>Radiation-induced fibrosis.</li><li>Chemotherapy-induced pneumonitis.</li><li>Fibrosis.</li><li>Cardiomyopathy.</li><li>Pulmonary embolism.</li><li>Respiratory muscle weakness.</li></ul></li><li><strong>Non-malignant causes of <strong class=\"gr-progress\">dyspnoea include:</strong></strong><ul><li>Pneumonia.</li><li>Chronic obstructive pulmonary disease.</li><li>Heart failure.</li><li>Pneumothorax.</li><li>Anxiety.</li><li>Obesity.</li><li>Fever.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Booth and Dudgeon, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Chan, 2015</a>]</p><!-- end field b995f8ec-7332-499c-b123-da7e3df1f04f --><!-- end item 949613d1-5c5f-44b4-be14-bddc610b1842 -->","topic":{"id":"20d4363b-caf3-55a9-beed-09266efa45f4","topicId":"73af552e-909d-456c-86d1-11f7a65040d8","topicName":"Palliative care - dyspnoea","slug":"palliative-care-dyspnoea","lastRevised":"Last revised in November 2020","chapters":[{"id":"0614f3a6-7238-5427-b059-9195b0cc2aa1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"738e7584-0909-59c3-bd54-43100aed01fe","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"ea721a0d-cda2-5620-8e3f-61e76920b9b3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"83260a2e-73f3-5abd-b049-c307d85d2cff","slug":"changes","fullItemName":"Changes"},{"id":"460710fb-be39-5a74-8adf-44beac90510f","slug":"update","fullItemName":"Update"}]},{"id":"a2422ca0-3b24-5c6e-81d8-07d257fdd44a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2753bf62-a22c-5fb2-936c-554ef07426d4","slug":"goals","fullItemName":"Goals"},{"id":"65f25469-16d4-5c7f-b7bc-a6698ca61164","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"52a827c5-48de-5c0c-8dce-6c7eeeab720d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"cd3e39be-06ce-5750-a1f7-cbc06bb58756","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"50c51a08-6607-5699-96a8-d66cb532d2c5","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"05dc5599-43b4-5340-841b-3b3208f4b947","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1fd04fd1-0023-5c48-9785-d9a54c7e2eb0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5a84982b-be4e-5901-a577-110f09001119","slug":"definition","fullItemName":"Definition"},{"id":"dab82422-38f4-5a30-b0db-ad2cbf33c2ab","slug":"prevalence-of-dyspnoea-in-palliative-care","fullItemName":"Prevalence of dyspnoea in palliative care"},{"id":"ea086054-ae8f-5666-9159-99b04676d230","slug":"causes-of-dyspnoea","fullItemName":"Causes of dyspnoea"},{"id":"c2601cd4-69b1-563f-870a-8110f4c24103","slug":"complications-of-dyspnoea","fullItemName":"Complications of dyspnoea"}]},{"id":"db288340-b73c-59b1-a8ba-4baec577b887","fullItemName":"Management","slug":"management","subChapters":[{"id":"62ed0387-08f9-5656-8079-a5fffee537f4","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"cdb4ccb3-9b96-5651-9950-6e2e0b8f4da0","slug":"symptomatic-treatment","fullItemName":"Scenario: Symptomatic treatment"},{"id":"5b9d65e3-1fc3-558d-a95e-5e4ff147c7d7","slug":"known-cause-of-dyspnoea","fullItemName":"Scenario: Known cause of dyspnoea"},{"id":"3b6b57e5-ba14-5311-bbf3-d996401c7dc6","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"},{"id":"9983f052-047c-5346-adfc-b741909ce269","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"08f118cb-d39f-532d-b39f-fa97739c656d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"22221f0a-e6f8-5976-bf6c-1024268816e0","slug":"oxygen","fullItemName":"Oxygen"},{"id":"25b01dc5-45e8-563d-872f-cfec63e33029","slug":"opioids","fullItemName":"Opioids"},{"id":"b7f561a2-0802-545a-b7d1-db218387a6e5","slug":"benzodiazepines","fullItemName":"Benzodiazepines"}]},{"id":"9f0bdd3b-82e3-5cbb-908f-d36a887457a8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5c3c7cfe-04b9-5ac4-9255-be56a20c7b5c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3aa322d7-2279-512c-93a7-55426d21da21","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b889ecee-814d-5e79-b596-a024fbee0acf","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e27fb69-52fd-5ddc-8f84-6164bb8615d0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c1800f44-6de2-534a-a4ff-32b8b5cf6e24","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6b7633c0-45a5-5a2e-b564-f185c2b9ef5f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2d28faa0-4a5f-565b-a431-6339d01f6e91","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"1fd04fd1-0023-5c48-9785-d9a54c7e2eb0","slug":"background-information","fullItemName":"Background information"},"subChapters":[{"id":"bd43fee7-c6cb-531c-ab86-e97bed77c3f6","slug":"further-information","fullItemName":"Further information","depth":3,"htmlHeader":"<!-- begin field f57e3a4c-0e0a-4aa3-bf42-1669650ba0da --><h3>Malignant causes of dyspnoea - further information</h3><!-- end field f57e3a4c-0e0a-4aa3-bf42-1669650ba0da -->","summary":null,"htmlStringContent":"<!-- begin item edc81db6-6714-4688-9669-3a0bb24bd762 --><!-- begin field 1b7ff42e-d1b6-4553-a146-5273725dcfe6 --><ul><li><strong>Upper airway obstruction </strong>can be caused by intraluminal tumour, spread of a primary bronchial carcinoma into the base of the trachea, or extrinsic compression by a tumour or mediastinal masses. It is a potentially life-threatening cause of dyspnoea but may be reversible:<ul><li>Dyspnoea is a common presentation of major airway obstruction. Other features that suggest the presence of upper airway obstruction include stridor, wheeze not responding to bronchodilators, lung collapse, and persistent cough or haemoptysis with a normal chest radiograph [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Chan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Stradling and Craig, 2010</a>].</li></ul></li><li><strong>Superior vena cava (SVC) obstruction </strong>is usually due to metastases in the upper mediastinal lymph nodes that cause extrinsic pressure, but it can also be caused by intraluminal thrombosis, external compression by the tumour, or direct invasion of the vessel wall by the tumour. Around 80% of cases are caused by lung cancer:<ul><li>Half of people with SVC obstruction experience dyspnoea; other common symptoms include neck and facial swelling, venous distention, a choking sensation, and a feeling of fullness in the head.</li><li>Major airway obstruction may occur if the tumour causing the SVC obstruction is also compressing the trachea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Davis, 1997</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Chan, 2015</a>].</li></ul></li><li><strong>Bronchial obstruction </strong>by the tumour may lead to loss of lung volume by causing collapse or by predisposing to consolidation distal to the tumour.</li><li><strong>A pleural effusion </strong>forms when excess pleural fluid is produced and/or not enough is reabsorbed. Clinically, it is detectable when at least 500 mL of fluid is present:<ul><li>In people with cancer, pleural effusion often occurs due to the tumour obstructing lymphatic transport in the pleura or regional lymph nodes. Most pleural effusions in the setting of cancer occur in people with lung, breast, or ovarian cancer, or lymphoma [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Twycross and Wilcock, 2001</a>].</li></ul></li><li><strong>Pericardial effusion </strong>can occur when the pericardium becomes infiltrated with tumour, and lymphatic and venous drainage of the pericardium is obstructed:<ul><li>Cancers which can cause pericardial effusion include breast, lung, and melanoma. Symptoms include dyspnoea, orthopnoea, and cough.</li><li>If the effusion increases in volume, cardiac tamponade can occur [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Chan, 2015</a>].</li></ul></li><li><strong>Lymphangitis carcinomatosa </strong>is caused by diffuse infiltration of lymphatic vessels in the lungs by malignant disease (most commonly breast and primary lung tumours). This obstructs pulmonary lymphatic drainage and leads to pulmonary congestion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Twycross et al, 2009</a>].</li></ul><!-- end field 1b7ff42e-d1b6-4553-a146-5273725dcfe6 --><!-- end item edc81db6-6714-4688-9669-3a0bb24bd762 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}